{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T14:46:57Z","timestamp":1700232417774},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1053\/beog.2002.0330","type":"journal-article","created":{"date-parts":[[2002,12,10]],"date-time":"2002-12-10T20:48:30Z","timestamp":1039553310000},"page":"645-657","source":"Crossref","is-referenced-by-count":5,"title":["Screening"],"prefix":"10.1053","volume":"16","author":[{"given":"Mark I","family":"Evans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric L","family":"Krivchenia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuval","family":"Yaron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beog.2002.0330_RF1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0095-5108(05)70082-8","article-title":"Principles of screening","volume":"28","author":"Evans","year":"2001","journal-title":"Clinics in Perinatology"},{"key":"10.1053\/beog.2002.0330_RF2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/0002-9378(95)91472-2","article-title":"MOMs and DADS: improved specificity and cost effectiveness of biochemical screening for aneuploidy with DADS","volume":"172","author":"Evans","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF3","first-page":"1","article-title":"Logistic regression generated probability estimates for trisomy 21 outcomes from serum AFP and BHCG: simplification with increased specificity","volume":"5","author":"Evans","year":"1996","journal-title":"Maternal and Fetal Medicine"},{"key":"10.1053\/beog.2002.0330_RF4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1096-8628(19960202)61:4<353::AID-AJMG9>3.0.CO;2-V","article-title":"Parental decisions to terminate\/continue following abnormal cytogenetic prenatal diagnosis: \u2018What\u2019 is still more important than \u2018when\u2019","volume":"61","author":"Evans","year":"1996","journal-title":"American Journal of Medical Genetics"},{"key":"10.1053\/beog.2002.0330_RF5","first-page":"52","article-title":"Determinants of parental decision to abort or continue for non-aneuploid ultrasound detected abnormalities","volume":"80","author":"Pryde","year":"1992","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(72)91634-0","article-title":"Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida","volume":"ii","author":"Brock","year":"1972","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(73)92592-0","article-title":"Prenatal diagnosis of anencephaly through maternal serum alpha-fetoprotein measurements","volume":"ii","author":"Brock","year":"1973","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archpedi.1992.02160190089028","article-title":"The changing epidemiology of neural tube defects: United States, 1968\u20131989","volume":"146","author":"Yen","year":"1992","journal-title":"American Journal of Diseases of Children"},{"key":"10.1053\/beog.2002.0330_RF9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.307.6906.703","article-title":"Prevalence of neural tube defects in South Australia, 1966\u201391: effectiveness and impact of prenatal diagnosis","volume":"307","author":"Chan","year":"1993","journal-title":"British Medical Journal"},{"key":"10.1053\/beog.2002.0330_RF10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006254-199305000-00002","article-title":"Update of new risk factors and prevention of neural-tube defects","volume":"48","author":"Steegers-Theunissen","year":"1993","journal-title":"Obstetric and Gynecologic Survey"},{"key":"10.1053\/beog.2002.0330_RF11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0015-0282(16)55428-4","article-title":"Neural tube defects after infertility treatment: a review","volume":"58","author":"Van Loon","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1053\/beog.2002.0330_RF12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.nu.05.070185.000555","article-title":"Vitamin B12 folate interrelationships","volume":"5","author":"Shane","year":"1985","journal-title":"Annual Review of Nutrition"},{"key":"10.1053\/beog.2002.0330_RF13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0095-5108(18)30928-X","article-title":"Folic acid and vitamin B12 deficiency in pregnancy and the neonatal period","volume":"11","author":"Shoiania","year":"1984","journal-title":"Clinics in Perinatology"},{"key":"10.1053\/beog.2002.0330_RF14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/adc.51.12.944","article-title":"Vitamin deficiencies and neural tube defects","volume":"51","author":"Smithells","year":"1976","journal-title":"Archives of Disease in Childhood"},{"key":"10.1053\/beog.2002.0330_RF15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(80)90886-7","article-title":"Possible prevention of neural-tube defects by periconceptional vitamin supplementation","volume":"i","author":"Smithells","year":"1980","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(83)92654-5","article-title":"Further experience of vitamin supplementation for prevention of neural-tube defect recurrences","volume":"i","author":"Smithells","year":"1983","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(89)92103-X","article-title":"Prevention of neural-tube defect recurrences in Yorkshire: final report","volume":"ii","author":"Smithells","year":"1989","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1056\/NEJM199101173240315","article-title":"Neural-tube defects and derangement of homocysteine metabolism","volume":"324","author":"Steegers-Theunissen","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beog.2002.0330_RF19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1399-0004.1987.tb02809.x","article-title":"Is disordered folate metabolism the basis for the genetic predisposition to neural-tube defects?","volume":"31","author":"Yates","year":"1987","journal-title":"Clinical Genetics"},{"key":"10.1053\/beog.2002.0330_RF20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1471-0528.1993.tb15306.x","article-title":"Investigation of factors influencing folate status in women who have had a neural tube defect-affected infant","volume":"100","author":"Wald","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2002.0330_RF21","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/adc.67.12.1436","article-title":"Long term effects of periconceptional multivitamin supplements for prevention of neural tube defects: a seven to 10 year follow up","volume":"67","author":"Holmes-Siedle","year":"1992","journal-title":"Archives of Disease in Childhood"},{"key":"10.1053\/beog.2002.0330_RF22","first-page":"1233","volume":"69","year":"1993","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beog.2002.0330_RF23","article-title":"Impact of Folic Acid Supplementation in the United States: markedly diminished Maternal Serum AFPs","author":"Evans","year":"2001","journal-title":"American College of Obstetrians and Gynecologists"},{"key":"10.1053\/beog.2002.0330_RF24","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.285.23.2981","article-title":"Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects","volume":"285","author":"Honein","year":"2001","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/beog.2002.0330_RF25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7863\/jum.1993.12.2.103","article-title":"Prenatal monographic findings of trisomy 18: review of 47 cases","volume":"2","author":"Nyberg","year":"1993","journal-title":"Journal of Ultrasound in Medicine"},{"key":"10.1053\/beog.2002.0330_RF27","series-title":"Reproductive Risks and Prenatal Diagnosis","first-page":"223","article-title":"Alpha-fetoprotein and biochemical screening","author":"Evans","year":"1992"},{"key":"10.1053\/beog.2002.0330_RF28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/bmj.297.6653.883","article-title":"Maternal serum screening for Down syndrome in early pregnancy","volume":"297","author":"Wald","year":"1988","journal-title":"British Medicine Journal"},{"key":"10.1053\/beog.2002.0330_RF29","first-page":"72","article-title":"A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol","volume":"81","author":"Cheng","year":"1993","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/pd.1970130804","article-title":"First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects","volume":"13","author":"Aitken","year":"1993","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/(SICI)1097-0223(199704)17:4<301::AID-PD969>3.0.CO;2-X","article-title":"Results of 12 years' combined maternal serum alpha-fetoprotein screening and ultrasound fetal monitoring for prenatal detection of fetal malformations in Havana City, Cuba","volume":"17","author":"Rodriguez","year":"1997","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1471-0528.1993.tb15307.x","article-title":"The use of free 1993, b-hCG in antenatal screening for Down's syndrome","volume":"100","author":"Wald","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2002.0330_RF33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/pd.1970140509","article-title":"Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme","volume":"14","author":"Goodburn","year":"1994","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF34","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1136\/bmj.306.6891.1509","article-title":"Risk assessment adjusted for gestational age in maternal serum screening for Down's syndrome","volume":"306","author":"Gardosi","year":"1993","journal-title":"British Medical Journal"},{"key":"10.1053\/beog.2002.0330_RF36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pd.1970110204","article-title":"Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alphafetoprotein, and age","volume":"11","author":"Crossley","year":"1991","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF37","first-page":"S111","article-title":"Standardization of methods reduces variability: explanation for the wide historical discrepancy in biochemical screening benefits","volume":"184","author":"Evans","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0140-6736(92)92349-K","article-title":"Maternal serum screening policy for Down's syndrome","volume":"340","author":"Cuckle","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF39","unstructured":"Evans, M, I, O'Brien, J, E, Dvorin, E, Standardization of methods reduces variability: explanation for the wide historical discrepancy among biochemical screening results, 2001"},{"key":"10.1053\/beog.2002.0330_RF40","first-page":"S111","article-title":"Maternal weight correction for alpha fetoprotein: mathematical truncations revisited","volume":"184","author":"Evans","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF41","unstructured":"Evans, M, I, Harrison, H, H, O'Brien, J, E, Correction for insulin dependent diabetes in maternal serum alpha fetoprotein testing has outlived its usefulness, American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF42","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/bmj.306.6886.1198-c","article-title":"Antenatal screening for Down's syndrome","volume":"306","author":"Wald","year":"1993","journal-title":"British Medical Journal"},{"key":"10.1053\/beog.2002.0330_RF43","first-page":"135","article-title":"Prospects for prenatal diagnosis by isolating fetal cells from maternal blood","volume":"7","author":"Elias","year":"1995","journal-title":"Contemporary Reviews in Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/(SICI)1097-0320(19960301)23:3<218::AID-CYTO5>3.0.CO;2-E","article-title":"Rare event selection of fetal nucleated erythrocytes in maternal blood by flow cytometry","volume":"23","author":"Lewis","year":"1996","journal-title":"Cytoymetry"},{"key":"10.1053\/beog.2002.0330_RF45","unstructured":"Bianchi, D, W, Simpson, J, L, Jackson, L, G, Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data, Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF46","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1073\/pnas.76.3.1453","article-title":"Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting","volume":"76","author":"Herzenberg","year":"1979","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beog.2002.0330_RF47","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1073\/pnas.87.9.3279","article-title":"Isolation of fetal DNA from nucleated erythrocytes in maternal blood","volume":"87","author":"Bianchi","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beog.2002.0330_RF48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1600-0897.1993.tb00620.x","article-title":"Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting","volume":"30","author":"Ganshirt-Ahlert","year":"1994","journal-title":"American Journal of Reproductive Immunology"},{"key":"10.1053\/beog.2002.0330_RF49","series-title":"Seventh International Conference on Early Prenatal Diagnosis","first-page":"19","article-title":"Noninvasive prentatal diagnosis: isolation of fetal cells from maternal circulation","author":"Ganshirt","year":"1994"},{"key":"10.1053\/beog.2002.0330_RF50","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0140-6736(93)93161-S","article-title":"Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers","volume":"341","author":"Lo","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF51","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0002-9378(96)70306-X","article-title":"Fetal RhD genotyping in fetal cells flow sorted from maternal blood","volume":"174","author":"Geifman-Holtzman","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/beog.2002.0330_RF52","article-title":"International, collaborative assessment of limitations of chromosome-specific probes and fluorescent in situ hybridization: analysis of expected detections in 73,000 prenatal cases","author":"Evans","year":"1994","journal-title":"American Society of Human Genetics"},{"key":"10.1053\/beog.2002.0330_RF53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/096914139600300202","article-title":"Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor and activin in Down's syndrome pregnancy","volume":"3","author":"Lambert-Messerlian","year":"1996","journal-title":"Journal of Medical Screening"},{"key":"10.1053\/beog.2002.0330_RF54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM199908123410701","article-title":"Integrated screening for Downs syndrome on the basis of tests performed during the first and second trimesters","volume":"341","author":"Wald","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beog.2002.0330_RF55","first-page":"271","article-title":"Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome!","volume":"73","author":"Drugan","year":"1989","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF56","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/pd.1970150806","article-title":"Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotrophin","volume":"15","author":"Palomaki","year":"1995","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF57","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1471-0528.1993.tb12973.x","article-title":"Low maternal serum levels of pregnancy associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype","volume":"100","author":"Brambati","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2002.0330_RF58","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/pd.1970141106","article-title":"Serum PAPP-A and free beta-hCG are first-trimester screening markers for Down syndrome","volume":"14","author":"Brambati","year":"1994","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0009-9120(97)00004-0","article-title":"Screening for Down syndrome during first trimester: a prospective study using free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A","volume":"30","author":"Forest","year":"1997","journal-title":"Clinical Biochemistry"},{"key":"10.1053\/beog.2002.0330_RF60","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pd.1970130704","article-title":"First-trimester free beta (hCG) screening for Down syndrome","volume":"13","author":"Macri","year":"1993","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF61","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0146-0005(99)80002-0","article-title":"First trimester screening for aneuploidy: serum biochemical markers","volume":"23","author":"Canick","year":"1999","journal-title":"Seminars in Perinatology"},{"key":"10.1053\/beog.2002.0330_RF62","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0002-9378(85)90385-0","article-title":"A sonographic sign for the detection in the second trimester of the fetus with Down's syndrome","volume":"151","author":"Benacerraf","year":"1985","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF63","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1471-0528.1994.tb11946.x","article-title":"Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy","volume":"101","author":"Nicolaides","year":"1994","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2002.0330_RF64","first-page":"420","article-title":"First-trimester fetal nuchal translucency thickness and risk for trisomies","volume":"84","author":"Pandya","year":"1994","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF65","doi-asserted-by":"crossref","unstructured":"Pandya, P, P, Snijders, R, J, Johnson, S, P, 1995, Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation, British Journal of Obstetrics and Gynaecology, 1995, 102, 957, 962","DOI":"10.1111\/j.1471-0528.1995.tb10902.x"},{"key":"10.1053\/beog.2002.0330_RF66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0140-6736(97)11280-6","article-title":"UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10\u201314 weeks of gestation","volume":"352","author":"Snijders","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-0528.1995.tb11289.x","article-title":"First trimester fetal nuchal translucency: problems with screening the general population. 1","volume":"102","author":"Roberts","year":"1995","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.2002.0330_RF68","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5","article-title":"Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome","volume":"17","author":"Wald","year":"1997","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF69","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pd.1970151305","article-title":"First trimester serum screening for Down's syndrome","volume":"15","author":"Wald","year":"1995","journal-title":"Prenatal Diagnosis"},{"key":"10.1053\/beog.2002.0330_RF70","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(97)80067-0","article-title":"Down's syndrome screening with nuchal translucency","volume":"349","author":"Nicolaides","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/beog.2002.0330_RF71","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0002-9378(01)80011-9","article-title":"First trimester aneuploid screening: results of the NICHD multicenter study","volume":"185","author":"Wapner","year":"2001","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1053\/beog.2002.0330_RF72","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM199908123410701","article-title":"Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters","volume":"341","author":"Wald","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beog.2002.0330_RF73","series-title":"Recommendations Arising from the 32nd Study Group: Screening for Down Syndrome in the First Trimester","author":"Grudzinskas","year":"1997"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693402903305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693402903305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T11:54:01Z","timestamp":1583927641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693402903305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S1521693402903305"],"URL":"https:\/\/doi.org\/10.1053\/beog.2002.0330","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}